Cities Changing Diabetes works in partnerships to fight the rise of diabetes in urban areas
Cities Changing Diabetes is a global program sponsored by Novo Nordisk in partnership with University College London and Steno Diabetes Center Copenhagen, in which nine cities around the world are learning how to improve diabetes prevention, detection and care in their communities. Urban areas have unique features and challenges, and this program aims to map the problem, share solutions and drive action to fight the diabetes challenge.
Houston was selected due to its challenging future with diabetes. The Cities Changing Diabetes program invested more than a year researching the diabetes epidemic there. A community-wide assessment identified the populations most at risk for developing the disease and developed profiles of those most at risk.
Through this localized research, profiles of Houstonians were established and the Cities Changing Diabetes program is able to think in new ways about people at risk for diabetes and prediabetes.
For more information about Cities Changing Diabetes globally, please visit www.citieschangingdiabetes.com.